COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Feasibility of Peripheral Angioplasty in Type D TASCII Lesions

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01297387
Recruitment Status : Completed
First Posted : February 16, 2011
Last Update Posted : February 21, 2011
Information provided by:
IRCCS Multimedica

Brief Summary:

This observational prospective study will evaluate, according o usual local clinical practice, feasibility of endoluminal revascularization in diabetic patients with type C and D lesions, according to TASC II Criteria.

About 300 patients will be treated with usual revascularization procedure. Each patient will be followed at least 12 months to evaluate clinical outcome and limb salvage interventions.

Condition or disease Intervention/treatment
Diabetes Critical Limb Ischemia Other: PTA BPG procedure,

Show Show detailed description

Layout table for study information
Study Type : Observational
Actual Enrollment : 344 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: An Observational, Prospective Study Evaluating Feasibility of Peripheral Angioplasty in Diabetic Patients With Critical Limb Ischemia in C and D Obstructions of Transatlantic Inter-Society Consensus (TASC II).
Study Start Date : January 2009
Actual Study Completion Date : December 2009

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Angioplasty

Group/Cohort Intervention/treatment
Revascularization of limb ischemia
Other: PTA BPG procedure,
Surgery PTA or BPG Procedure, according usual local clinical practice
Other Name: Peripheral angioplasty

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Diabetic patients with critical limb ischemia

Inclusion Criteria:

  • Adult diabetic patients type 1 or 2
  • Chronic critical ischemia as defined by TASC 2007 criteria (pain at rest, and/or ulcer or gangrene due to arteriopathy: transcutaneous oximetry < 30 mmHg or pressure on the ankle < 70 mmHg)

Exclusion Criteria:

  • Cancer with adverse prognosis in months, or chemotherapeutic treatment
  • Ongoing or planned pregnancy
  • Lack of consent to participate to the study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01297387

Layout table for location information
Diabetic Foot Center IRCCS MultiMedica
Sesto San Giovanni, Milano, Italy, 20099
Sponsors and Collaborators
IRCCS Multimedica
Layout table for investigator information
Principal Investigator: Ezio Faglia, MD Diabetic Foot Centre IRCCS MultiMedica
Layout table for additonal information
Responsible Party: Ezio faglia MD, Diabetic Foot Center IRCCS MultiMedica, Sesto San Giovanni Milano Identifier: NCT01297387    
Other Study ID Numbers: 08/2007_Cardiovascolare
First Posted: February 16, 2011    Key Record Dates
Last Update Posted: February 21, 2011
Last Verified: February 2011
Keywords provided by IRCCS Multimedica:
Diabetic Patients
Critical Limb Ischemia
Additional relevant MeSH terms:
Layout table for MeSH terms
Pathologic Processes